Tonghua Dongbao Pharmaceutical Co. Ltd Financials

Market Capitalization CN¥16.41 Billion as of Jan. 1, 2026

Valuations Metrics as of Jan. 3, 2026

Trailing PE	13.18
Forward PE	22.69
Price to Sales TTM	CN¥5.84
Price to Book MRQ	CN¥2.24
Enterprise to Revenue	5.51
Enterprise to EBITDA	24.13

Financial Reports as of Jun. 30, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-06-30
Profit Margin	44.72%
Operating Margin	24.13%
Return on Assets TTM	3.58%
Return on Equity TTM	17.84%

Income Statement

Revenue TTM	CN¥2,741,382,656
Revenue per Share TTM	CN¥1.40
Quarterly Revenue Growth	13.90%
Gross Profit TTM	CN¥1,950,798,080
EBITDA	CN¥473,909,396
Net Income to Common TTM	CN¥1,225,883,648
Diluted EPS TTM	CN¥0.62
Quarterly Earnings Growth YoY	499.90%

Balance Sheet

Total Cash MRQ	CN¥1,659,224,064
Total Cash per Share MRQ	CN¥0.85
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	10.96
Current Ratio MRQ	4.64
Book Value per Share MRQ	CN¥3.65

Cash Flow

Operating Cash Flow TTM	CN¥614,825,728
Levered Free Cash Flow TTM	CN¥343,026,784

600867 Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding	1,958,542,829
Float Shares	1,050,689,630
Avg 10 Volume	14,346,714
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	33.65%
% Held by Institutions	15.95%

Stock Price Summary

Beta	0.30
Fifty Two Week Low	CN¥7.00
Fifty Two Week High	CN¥9.67
Fifty Two Week Change	4.53%
Day 50 MA	CN¥8.76
Day 200 MA	CN¥8.21

Dividends and Splits

Forward Annual Dividend Rate	CN¥1.00
Forward Annual Dividend Yield	12.24%
Trailing Annual Dividend Rate	CN¥0.25
Trailing Annual Dividend Yield	3.06%
Payout Ratio	40.32%
Dividend Date
Ex Dividend Date	2025-06-25
Last Split Factor
Last Split Date	2018-05-25